Startup draws $3 million investment from Japanese biotech firm

Unleash Immuno Oncolystics founder Daniel Curiel said the biotech industry is at a "tipping point" with established companies adopting the new technology.

Source: bizjournals.com Health Care:Biotechnology headlines - February 19, 2018 Category: Biotechnology Authors: Steph Kukuljan Source Type: news